APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cholera Vaccine (Oral Route)

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Cholera Vaccine (Oral Route) Industry Growth and Trends Forecast to 2032

26 December 202579 pages

Choose your research edition.

Industry ResearchCholera Vaccine (Oral Route) Industry Research Report 2026109 pages · $2,950 USDIndustry Growth & TrendsGlobal Cholera Vaccine (Oral Route) Industry Growth and Trends Forecast to 203279 pages · $3,450 USDMarket StructureGlobal Cholera Vaccine (Oral Route) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032174 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cholera Vaccine (Oral Route) Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Cholera Vaccine (Oral Route) Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Cholera Vaccine (Oral Route) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Cholera Vaccine (Oral Route) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Cholera Vaccine (Oral Route) is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cholera Vaccine (Oral Route) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Cholera Vaccine (Oral Route) include EuBiologics, PaxVax, Valneva and Sanofi, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Cholera Vaccine (Oral Route) market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Cholera Vaccine (Oral Route) market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Cholera Vaccine (Oral Route) market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Cholera Vaccine (Oral Route).

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Cholera Vaccine (Oral Route) market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Cholera Vaccine (Oral Route) Market by Company

EuBiologics

PaxVax

Valneva

Sanofi

Cholera Vaccine (Oral Route) Segment by Type

Dukoral

Shanchol

Vaxchora

Others

Cholera Vaccine (Oral Route) Segment by Application

Pharmaceutical & Biotechnology Companies

Hospital

Research & Academic Laboratories

Others

Cholera Vaccine (Oral Route) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cholera Vaccine (Oral Route) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cholera Vaccine (Oral Route) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cholera Vaccine (Oral Route).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Cholera Vaccine (Oral Route) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Cholera Vaccine (Oral Route) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Dukoral Table 2. Major Company of Shanchol Table 3. Major Company of Vaxchora Table 4. Major Company of Others Table 5. Global Cholera Vaccine (Oral Route) Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Cholera Vaccine (Oral Route) Sales by Type (2021-2026) & (K Units) Table 7. Global Cholera Vaccine (Oral Route) Sales Market Share in Volume by Type (2021-2026) Table 8. Global Cholera Vaccine (Oral Route) Sales by Type (2021-2026) & (US$ Million) Table 9. Global Cholera Vaccine (Oral Route) Sales Market Share in Value by Type (2021-2026) Table 10. Global Cholera Vaccine (Oral Route) Price by Type (2021-2026) & (US$/Unit) Table 11. Global Cholera Vaccine (Oral Route) Sales by Type (2027-2032) & (K Units) Table 12. Global Cholera Vaccine (Oral Route) Sales Market Share in Volume by Type (2027-2032) Table 13. Global Cholera Vaccine (Oral Route) Sales by Type (2027-2032) & (US$ Million) Table 14. Global Cholera Vaccine (Oral Route) Sales Market Share in Value by Type (2027-2032) Table 15. Global Cholera Vaccine (Oral Route) Price by Type (2027-2032) & (US$/Unit) Table 16. North America Cholera Vaccine (Oral Route) Sales by Type (2021-2026) & (K Units) Table 17. North America Cholera Vaccine (Oral Route) Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Cholera Vaccine (Oral Route) Sales by Type (2021-2026) & (K Units) Table 19. Europe Cholera Vaccine (Oral Route) Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Cholera Vaccine (Oral Route) Sales by Type (2021-2026) & (K Units) Table 21. Asia-Pacific Cholera Vaccine (Oral Route) Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Cholera Vaccine (Oral Route) Sales by Type (2021-2026) & (K Units) Table 23. Latin America Cholera Vaccine (Oral Route) Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Cholera Vaccine (Oral Route) Sales by Type (2021-2026) & (K Units) Table 25. Middle East and Africa Cholera Vaccine (Oral Route) Sales by Type (2021-2026) & (US$ Million) Table 26. Cholera Vaccine (Oral Route) Industry Trends Table 27. Cholera Vaccine (Oral Route) Industry Drivers Table 28. Cholera Vaccine (Oral Route) Industry Opportunities and Challenges Table 29. Cholera Vaccine (Oral Route) Industry Restraints Table 30. Global Cholera Vaccine (Oral Route) Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Cholera Vaccine (Oral Route) Revenue Market Share by Company (2021-2026) Table 32. Global Cholera Vaccine (Oral Route) Sales by Company (2021-2026) & (K Units) Table 33. Global Cholera Vaccine (Oral Route) Sales Share by Company (2021-2026) Table 34. Global Cholera Vaccine (Oral Route) Market Price by Company (2021-2026) & (US$/Unit) Table 35. Global Cholera Vaccine (Oral Route) Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Cholera Vaccine (Oral Route) Major Company Production Sites and Headquarters Table 37. Global Cholera Vaccine (Oral Route) Company, Product Type & Application Table 38. Global Cholera Vaccine (Oral Route) Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Cholera Vaccine (Oral Route) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Cholera Vaccine (Oral Route) Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Cholera Vaccine (Oral Route) Sales by Region (2021-2026) & (K Units) Table 43. Global Cholera Vaccine (Oral Route) Sales Market Share in Volume by Region (2021-2026) Table 44. Global Cholera Vaccine (Oral Route) Sales by Region (2021-2026) & (US$ Million) Table 45. Global Cholera Vaccine (Oral Route) Sales Market Share in Value by Region (2021-2026) Table 46. Global Cholera Vaccine (Oral Route) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 47. Global Cholera Vaccine (Oral Route) Sales by Region (2027-2032) & (K Units) Table 48. Global Cholera Vaccine (Oral Route) Sales Market Share in Volume by Region (2027-2032) Table 49. Global Cholera Vaccine (Oral Route) Sales by Region (2027-2032) & (US$ Million) Table 50. Global Cholera Vaccine (Oral Route) Sales Market Share in Value by Region (2027-2032) Table 51. Global Cholera Vaccine (Oral Route) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 52. Global Cholera Vaccine (Oral Route) Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Cholera Vaccine (Oral Route) Sales by Application (2021-2026) & (K Units) Table 54. Global Cholera Vaccine (Oral Route) Sales Market Share in Volume by Application (2021-2026) Table 55. Global Cholera Vaccine (Oral Route) Sales by Application (2021-2026) & (US$ Million) Table 56. Global Cholera Vaccine (Oral Route) Sales Market Share in Value by Application (2021-2026) Table 57. Global Cholera Vaccine (Oral Route) Price by Application (2021-2026) & (US$/Unit) Table 58. Global Cholera Vaccine (Oral Route) Sales by Application (2027-2032) & (K Units) Table 59. Global Cholera Vaccine (Oral Route) Sales Market Share in Volume by Application (2027-2032) Table 60. Global Cholera Vaccine (Oral Route) Sales by Application (2027-2032) & (US$ Million) Table 61. Global Cholera Vaccine (Oral Route) Sales Market Share in Value by Application (2027-2032) Table 62. Global Cholera Vaccine (Oral Route) Price by Application (2027-2032) & (US$/Unit) Table 63. North America Cholera Vaccine (Oral Route) Sales by Application (2021-2026) & (K Units) Table 64. North America Cholera Vaccine (Oral Route) Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Cholera Vaccine (Oral Route) Sales by Application (2021-2026) & (K Units) Table 66. Europe Cholera Vaccine (Oral Route) Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Cholera Vaccine (Oral Route) Sales by Application (2021-2026) & (K Units) Table 68. Asia-Pacific Cholera Vaccine (Oral Route) Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Cholera Vaccine (Oral Route) Sales by Application (2021-2026) & (K Units) Table 70. Latin America Cholera Vaccine (Oral Route) Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Cholera Vaccine (Oral Route) Sales by Application (2021-2026) & (K Units) Table 72. Middle East and Africa Cholera Vaccine (Oral Route) Sales by Application (2021-2026) & (US$ Million) Table 73. EuBiologics Company Information Table 74. EuBiologics Business Overview Table 75. EuBiologics Cholera Vaccine (Oral Route) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. EuBiologics Cholera Vaccine (Oral Route) Product Portfolio Table 77. EuBiologics Recent Development Table 78. PaxVax Company Information Table 79. PaxVax Business Overview Table 80. PaxVax Cholera Vaccine (Oral Route) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. PaxVax Cholera Vaccine (Oral Route) Product Portfolio Table 82. PaxVax Recent Development Table 83. Valneva Company Information Table 84. Valneva Business Overview Table 85. Valneva Cholera Vaccine (Oral Route) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Valneva Cholera Vaccine (Oral Route) Product Portfolio Table 87. Valneva Recent Development Table 88. Sanofi Company Information Table 89. Sanofi Business Overview Table 90. Sanofi Cholera Vaccine (Oral Route) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Sanofi Cholera Vaccine (Oral Route) Product Portfolio Table 92. Sanofi Recent Development Table 93. North America Cholera Vaccine (Oral Route) Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 94. North America Cholera Vaccine (Oral Route) Sales by Country (2021-2026) & (K Units) Table 95. North America Cholera Vaccine (Oral Route) Sales Market Share by Country (2021-2026) Table 96. North America Cholera Vaccine (Oral Route) Sales Forecast by Country (2027-2032) & (K Units) Table 97. North America Cholera Vaccine (Oral Route) Sales Market Share Forecast by Country (2027-2032) Table 98. North America Cholera Vaccine (Oral Route) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 99. North America Cholera Vaccine (Oral Route) Market Size by Country (2021-2026) & (US$ Million) Table 100. North America Cholera Vaccine (Oral Route) Market Share by Country (2021-2026) Table 101. North America Cholera Vaccine (Oral Route) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 102. North America Cholera Vaccine (Oral Route) Market Share Forecast by Country (2027-2032) Table 103. Europe Cholera Vaccine (Oral Route) Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 104. Europe Cholera Vaccine (Oral Route) Sales by Country (2021-2026) & (K Units) Table 105. Europe Cholera Vaccine (Oral Route) Sales Market Share by Country (2021-2026) Table 106. Europe Cholera Vaccine (Oral Route) Sales Forecast by Country (2027-2032) & (K Units) Table 107. Europe Cholera Vaccine (Oral Route) Sales Market Share Forecast by Country (2027-2032) Table 108. Europe Cholera Vaccine (Oral Route) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 109. Europe Cholera Vaccine (Oral Route) Market Size by Country (2021-2026) & (US$ Million) Table 110. Europe Cholera Vaccine (Oral Route) Market Share by Country (2021-2026) Table 111. Europe Cholera Vaccine (Oral Route) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 112. Europe Cholera Vaccine (Oral Route) Market Share Forecast by Country (2027-2032) Table 113. Asia-Pacific Cholera Vaccine (Oral Route) Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 114. Asia-Pacific Cholera Vaccine (Oral Route) Sales by Country (2021-2026) & (K Units) Table 115. Asia-Pacific Cholera Vaccine (Oral Route) Sales Market Share by Country (2021-2026) Table 116. Asia-Pacific Cholera Vaccine (Oral Route) Sales Forecast by Country (2027-2032) & (K Units) Table 117. Asia-Pacific Cholera Vaccine (Oral Route) Sales Market Share Forecast by Country (2027-2032) Table 118. Asia-Pacific Cholera Vaccine (Oral Route) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. Asia-Pacific Cholera Vaccine (Oral Route) Market Size by Country (2021-2026) & (US$ Million) Table 120. Asia-Pacific Cholera Vaccine (Oral Route) Market Share by Country (2021-2026) Table 121. Asia-Pacific Cholera Vaccine (Oral Route) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. Asia-Pacific Cholera Vaccine (Oral Route) Market Share Forecast by Country (2027-2032) Table 123. Latin America Cholera Vaccine (Oral Route) Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 124. Latin America Cholera Vaccine (Oral Route) Sales by Country (2021-2026) & (K Units) Table 125. Latin America Cholera Vaccine (Oral Route) Sales Market Share by Country (2021-2026) Table 126. Latin America Cholera Vaccine (Oral Route) Sales Forecast by Country (2027-2032) & (K Units) Table 127. Latin America Cholera Vaccine (Oral Route) Sales Market Share Forecast by Country (2027-2032) Table 128. Latin America Cholera Vaccine (Oral Route) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Latin America Cholera Vaccine (Oral Route) Market Size by Country (2021-2026) & (US$ Million) Table 130. Latin America Cholera Vaccine (Oral Route) Market Share by Country (2021-2026) Table 131. Latin America Cholera Vaccine (Oral Route) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Latin America Cholera Vaccine (Oral Route) Market Share Forecast by Country (2027-2032) Table 133. Middle East and Africa Cholera Vaccine (Oral Route) Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 134. Middle East and Africa Cholera Vaccine (Oral Route) Sales by Country (2021-2026) & (K Units) Table 135. Middle East and Africa Cholera Vaccine (Oral Route) Sales Market Share by Country (2021-2026) Table 136. Middle East and Africa Cholera Vaccine (Oral Route) Sales Forecast by Country (2027-2032) & (K Units) Table 137. Middle East and Africa Cholera Vaccine (Oral Route) Sales Market Share Forecast by Country (2027-2032) Table 138. Middle East and Africa Cholera Vaccine (Oral Route) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Middle East and Africa Cholera Vaccine (Oral Route) Market Size by Country (2021-2026) & (US$ Million) Table 140. Middle East and Africa Cholera Vaccine (Oral Route) Market Share by Country (2021-2026) Table 141. Middle East and Africa Cholera Vaccine (Oral Route) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Middle East and Africa Cholera Vaccine (Oral Route) Market Share Forecast by Country (2027-2032) Table 143. Key Raw Materials Table 144. Raw Materials Key Suppliers Table 145. Cholera Vaccine (Oral Route) Distributors List Table 146. Cholera Vaccine (Oral Route) Customers List Table 147. Research Programs/Design for This Report Table 148. Authors List of This Report Table 149. Secondary Sources Table 150. Primary Sources List of Figures Figure 1. Cholera Vaccine (Oral Route) Image Figure 2. Global Cholera Vaccine (Oral Route) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cholera Vaccine (Oral Route) Market Size (2021-2032) & (US$ Million) Figure 4. Global Cholera Vaccine (Oral Route) Sales (2021-2032) & (K Units) Figure 5. Dukoral Image Figure 6. Global Dukoral Sales YoY Growth (2021-2032) & (K Units) Figure 7. Shanchol Image Figure 8. Global Shanchol Sales YoY Growth (2021-2032) & (K Units) Figure 9. Vaxchora Image Figure 10. Global Vaxchora Sales YoY Growth (2021-2032) & (K Units) Figure 11. Others Image Figure 12. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 13. Global Cholera Vaccine (Oral Route) Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Cholera Vaccine (Oral Route) Market Share by Type 2025 VS 2032 Figure 15. North America Cholera Vaccine (Oral Route) Sales Market Share in Volume by Type in 2025 Figure 16. North America Cholera Vaccine (Oral Route) Sales Market Share in Value by Type in 2025 Figure 17. Europe Cholera Vaccine (Oral Route) Sales Market Share in Volume by Type in 2025 Figure 18. Europe Cholera Vaccine (Oral Route) Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Cholera Vaccine (Oral Route) Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Cholera Vaccine (Oral Route) Sales Market Share in Value by Type in 2025 Figure 21. Latin America Cholera Vaccine (Oral Route) Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Cholera Vaccine (Oral Route) Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Cholera Vaccine (Oral Route) Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Cholera Vaccine (Oral Route) Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Cholera Vaccine (Oral Route) Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Pharmaceutical & Biotechnology Companies Image Figure 28. Global Pharmaceutical & Biotechnology Companies Sales YoY Growth (2021-2032) & (K Units) Figure 29. Hospital Image Figure 30. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 31. Research & Academic Laboratories Image Figure 32. Global Research & Academic Laboratories Sales YoY Growth (2021-2032) & (K Units) Figure 33. Others Image Figure 34. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 35. Global Cholera Vaccine (Oral Route) Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Cholera Vaccine (Oral Route) Market Share by Application 2025 VS 2032 Figure 37. North America Cholera Vaccine (Oral Route) Sales Market Share in Volume by Application in 2025 Figure 38. North America Cholera Vaccine (Oral Route) Sales Market Share in Value by Application in 2025 Figure 39. Europe Cholera Vaccine (Oral Route) Sales Market Share in Volume by Application in 2025 Figure 40. Europe Cholera Vaccine (Oral Route) Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Cholera Vaccine (Oral Route) Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Cholera Vaccine (Oral Route) Sales Market Share in Value by Application in 2025 Figure 43. Latin America Cholera Vaccine (Oral Route) Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Cholera Vaccine (Oral Route) Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Cholera Vaccine (Oral Route) Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Cholera Vaccine (Oral Route) Sales Market Share in Value by Application in 2025 Figure 47. North America Cholera Vaccine (Oral Route) Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. North America Cholera Vaccine (Oral Route) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Cholera Vaccine (Oral Route) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Cholera Vaccine (Oral Route) Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Cholera Vaccine (Oral Route) Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Europe Cholera Vaccine (Oral Route) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Cholera Vaccine (Oral Route) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Cholera Vaccine (Oral Route) Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Cholera Vaccine (Oral Route) Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Asia-Pacific Cholera Vaccine (Oral Route) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Cholera Vaccine (Oral Route) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Cholera Vaccine (Oral Route) Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Cholera Vaccine (Oral Route) Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Latin America Cholera Vaccine (Oral Route) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Cholera Vaccine (Oral Route) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Cholera Vaccine (Oral Route) Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Cholera Vaccine (Oral Route) Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Middle East and Africa Cholera Vaccine (Oral Route) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Cholera Vaccine (Oral Route) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Cholera Vaccine (Oral Route) Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Cholera Vaccine (Oral Route) Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Cholera Vaccine (Oral Route) Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Dukoral
  • Shanchol
  • Vaxchora
  • Others
Applications
  • Pharmaceutical & Biotechnology Companies
  • Hospital
  • Research & Academic Laboratories
  • Others
Companies covered
  • EuBiologics
  • PaxVax
  • Valneva
  • Sanofi

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Cholera Vaccine (Oral Route) Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Cholera Vaccine (Oral Route) Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Cholera Vaccine (Oral Route) Market by Type
  6. 1.3.1 Dukoral
  7. 1.3.2 Shanchol
  8. 1.3.3 Vaxchora
  9. 1.3.4 Others
  10. 1.4 Global Cholera Vaccine (Oral Route) Market Size by Type
  11. 1.4.1 Global Cholera Vaccine (Oral Route) Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Cholera Vaccine (Oral Route) Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Cholera Vaccine (Oral Route) Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Cholera Vaccine (Oral Route) Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Cholera Vaccine (Oral Route) Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Cholera Vaccine (Oral Route) Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Cholera Vaccine (Oral Route) Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Cholera Vaccine (Oral Route) Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Cholera Vaccine (Oral Route) Industry Trends
  2. 2.2 Cholera Vaccine (Oral Route) Industry Drivers
  3. 2.3 Cholera Vaccine (Oral Route) Industry Opportunities and Challenges
  4. 2.4 Cholera Vaccine (Oral Route) Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Cholera Vaccine (Oral Route) Revenue (2021-2026)
  2. 3.2 Global Top Players by Cholera Vaccine (Oral Route) Sales (2021-2026)
  3. 3.3 Global Top Players by Cholera Vaccine (Oral Route) Price (2021-2026)
  4. 3.4 Global Cholera Vaccine (Oral Route) Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Cholera Vaccine (Oral Route) Major Company Production Sites & Headquarters
  6. 3.6 Global Cholera Vaccine (Oral Route) Company, Product Type & Application
  7. 3.7 Global Cholera Vaccine (Oral Route) Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Cholera Vaccine (Oral Route) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Cholera Vaccine (Oral Route) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Cholera Vaccine (Oral Route) Tier 1, Tier 2, and Tier 3
4 Cholera Vaccine (Oral Route) Regional Status and Outlook
  1. 4.1 Global Cholera Vaccine (Oral Route) Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Cholera Vaccine (Oral Route) Historic Market Size by Region
  3. 4.2.1 Global Cholera Vaccine (Oral Route) Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Cholera Vaccine (Oral Route) Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Cholera Vaccine (Oral Route) Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Cholera Vaccine (Oral Route) Forecasted Market Size by Region
  7. 4.3.1 Global Cholera Vaccine (Oral Route) Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Cholera Vaccine (Oral Route) Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Cholera Vaccine (Oral Route) Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Cholera Vaccine (Oral Route) by Application
  1. 5.1 Cholera Vaccine (Oral Route) Market by Application
  2. 5.1.1 Pharmaceutical & Biotechnology Companies
  3. 5.1.2 Hospital
  4. 5.1.3 Research & Academic Laboratories
  5. 5.1.4 Others
  6. 5.2 Global Cholera Vaccine (Oral Route) Market Size by Application
  7. 5.2.1 Global Cholera Vaccine (Oral Route) Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Cholera Vaccine (Oral Route) Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Cholera Vaccine (Oral Route) Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Cholera Vaccine (Oral Route) Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Cholera Vaccine (Oral Route) Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Cholera Vaccine (Oral Route) Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Cholera Vaccine (Oral Route) Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Cholera Vaccine (Oral Route) Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 EuBiologics
  2. 6.1.1 EuBiologics Company Information
  3. 6.1.2 EuBiologics Business Overview
  4. 6.1.3 EuBiologics Cholera Vaccine (Oral Route) Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 EuBiologics Cholera Vaccine (Oral Route) Product Portfolio
  6. 6.1.5 EuBiologics Recent Developments
  7. 6.2 PaxVax
  8. 6.2.1 PaxVax Company Information
  9. 6.2.2 PaxVax Business Overview
  10. 6.2.3 PaxVax Cholera Vaccine (Oral Route) Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 PaxVax Cholera Vaccine (Oral Route) Product Portfolio
  12. 6.2.5 PaxVax Recent Developments
  13. 6.3 Valneva
  14. 6.3.1 Valneva Company Information
  15. 6.3.2 Valneva Business Overview
  16. 6.3.3 Valneva Cholera Vaccine (Oral Route) Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Valneva Cholera Vaccine (Oral Route) Product Portfolio
  18. 6.3.5 Valneva Recent Developments
  19. 6.4 Sanofi
  20. 6.4.1 Sanofi Company Information
  21. 6.4.2 Sanofi Business Overview
  22. 6.4.3 Sanofi Cholera Vaccine (Oral Route) Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Sanofi Cholera Vaccine (Oral Route) Product Portfolio
  24. 6.4.5 Sanofi Recent Developments
7 North America by Country
  1. 7.1 North America Cholera Vaccine (Oral Route) Sales by Country
  2. 7.1.1 North America Cholera Vaccine (Oral Route) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Cholera Vaccine (Oral Route) Sales by Country (2021-2026)
  4. 7.1.3 North America Cholera Vaccine (Oral Route) Sales Forecast by Country (2027-2032)
  5. 7.2 North America Cholera Vaccine (Oral Route) Market Size by Country
  6. 7.2.1 North America Cholera Vaccine (Oral Route) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Cholera Vaccine (Oral Route) Market Size by Country (2021-2026)
  8. 7.2.3 North America Cholera Vaccine (Oral Route) Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Cholera Vaccine (Oral Route) Sales by Country
  2. 8.1.1 Europe Cholera Vaccine (Oral Route) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Cholera Vaccine (Oral Route) Sales by Country (2021-2026)
  4. 8.1.3 Europe Cholera Vaccine (Oral Route) Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Cholera Vaccine (Oral Route) Market Size by Country
  6. 8.2.1 Europe Cholera Vaccine (Oral Route) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Cholera Vaccine (Oral Route) Market Size by Country (2021-2026)
  8. 8.2.3 Europe Cholera Vaccine (Oral Route) Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Cholera Vaccine (Oral Route) Sales by Country
  2. 9.1.1 Asia-Pacific Cholera Vaccine (Oral Route) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Cholera Vaccine (Oral Route) Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Cholera Vaccine (Oral Route) Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Cholera Vaccine (Oral Route) Market Size by Country
  6. 9.2.1 Asia-Pacific Cholera Vaccine (Oral Route) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Cholera Vaccine (Oral Route) Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Cholera Vaccine (Oral Route) Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Cholera Vaccine (Oral Route) Sales by Country
  2. 10.1.1 South America Cholera Vaccine (Oral Route) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Cholera Vaccine (Oral Route) Sales by Country (2021-2026)
  4. 10.1.3 South America Cholera Vaccine (Oral Route) Sales Forecast by Country (2027-2032)
  5. 10.2 South America Cholera Vaccine (Oral Route) Market Size by Country
  6. 10.2.1 South America Cholera Vaccine (Oral Route) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Cholera Vaccine (Oral Route) Market Size by Country (2021-2026)
  8. 10.2.3 South America Cholera Vaccine (Oral Route) Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Cholera Vaccine (Oral Route) Sales by Country
  2. 11.1.1 Middle East and Africa Cholera Vaccine (Oral Route) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Cholera Vaccine (Oral Route) Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Cholera Vaccine (Oral Route) Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Cholera Vaccine (Oral Route) Market Size by Country
  6. 11.2.1 Middle East and Africa Cholera Vaccine (Oral Route) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Cholera Vaccine (Oral Route) Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Cholera Vaccine (Oral Route) Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Cholera Vaccine (Oral Route) Value Chain Analysis
  2. 12.1.1 Cholera Vaccine (Oral Route) Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Cholera Vaccine (Oral Route) Production Mode & Process
  7. 12.2 Cholera Vaccine (Oral Route) Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Cholera Vaccine (Oral Route) Distributors
  10. 12.2.3 Cholera Vaccine (Oral Route) Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst